|
시장보고서
상품코드
1964243
반려동물 액체생검 시장 규모, 점유율, 성장 분석 : 제품별, 순환 바이오마커별, 기술별, 용도별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)Pet Liquid Biopsy Market Size, Share, and Growth Analysis, By Product, By Circulating Biomarkers, By Technology, By Application, By End Use, By Region - Industry Forecast 2026-2033 |
||||||
세계의 반려동물 액체생검 시장 규모는 2024년에 2억 4,560만 달러로 평가되었고, 2025년 2억 8,367만 달러에서 2033년까지 8억 9,839만 달러로 성장할 전망입니다. 또한 예측 기간(2026-2033년) CAGR은 15.5%를 나타낼 것으로 예측됩니다.
세계 반려동물 액체생검 분야 시장 분석에 따르면, 반려동물 양육률 증가와 동물 의료비 증가를 배경으로 비침습적 암 진단법에 대한 수요가 증가하고 있는 것으로 나타났습니다. 본 시장에서는 종양 유래 세포 유리 DNA를 검출하는 혈액검사가 주류를 이루고 있으며, 반려동물의 조기발견, 병기판정, 치료 경과 관찰을 가능하게 합니다. 반려동물 보호자들이 가족과 같은 수준 높은 치료 옵션을 요구하면서 혁신적인 진단 기술에 대한 요구가 더욱 커지고 있습니다. 이 분야는 인간 종양학에서 발전하여 개와 고양이를 위한 검사법을 개발하는 기업이 증가하고 있습니다. 전문 클리닉에서의 조기 도입으로 그 임상적 가치가 입증되고 있습니다. 또한, AI 기술은 저농도 종양 신호 검출 능력을 향상시키고, 분자 데이터와 세포진단을 연계하여 진단의 정확도를 높입니다. 이를 통해 워크플로우를 효율화하여 환자 치료의 향상을 위한 보급을 촉진하고 있습니다.
세계 반려동물 액체생검 시장 성장 촉진요인
반려동물의 암 위험에 대한 인식이 높아지면서 비침습적 진단 솔루션에 대한 보호자들의 관심이 높아짐에 따라 액체생검 검사에 대한 관심이 크게 증가하고 있습니다. 수의학 전문가들은 외과적 개입 없이도 조기 발견을 촉진하고 치료 방침을 결정하는 데 도움을 주는 기술을 높이 평가했습니다. 액체생검은 동물의 스트레스를 최소화하면서 정기적인 모니터링과 시료 채취를 가능하게 하는 수단을 제공함으로써 이러한 요건을 충족합니다. 보호자의 의지와 임상적 평가가 일치함에 따라 액체생검 서비스 도입 확대의 길이 열리고, 시장의 잠재력이 확대되는 동시에 관련 기술 혁신과 서비스 제공에 대한 투자가 촉진되고 있습니다.
세계 반려동물 액체생검 시장 성장 억제요인
세계 반려동물 액체생검 시장은 고급 수의 진단에 대한 보험 적용 범위의 부족과 제한된 상환 옵션으로 인해 심각한 제약에 직면해 있습니다. 이러한 상황은 반려동물 보호자의 자부담 비용 증가로 이어져 액체생검 검사를 주저하게 만드는 요인이 되고, 결국 동물병원의 수익 안정성에 영향을 미치게 됩니다. 확립된 보상 체계의 부재는 수의사가 이러한 진단 검사를 권장하는 것을 주저하게 만드는 요인이 될 수 있는데, 이는 고객에게 경제적 부담을 줄 수 있기 때문입니다. 또한, 소규모 동물병원의 경우, 필요한 기술에 대한 투자에 대한 불확실성이 발생할 수 있으며, 이는 액체생검의 일상적인 사용을 방해하여 전체 시장의 성장과 지속가능성을 저해할 수 있습니다.
세계 반려동물 액체생검 시장 동향
세계 반려동물 액체생검 시장에서는 반려동물의 편의성과 저침습성을 원하는 보호자의 니즈를 배경으로 재택검사로의 전환이 눈에 띄게 진행되고 있습니다. 각 제조업체들은 검사의 순응도를 높이고 조기 질병 발견을 촉진하기 위해 간소화된 검체 채취 장치와 알기 쉬운 설명서를 개발하는 데 주력하고 있습니다. 동물병원과 원격의료 서비스 제공업체들은 이러한 재택 검사 솔루션을 진료 프로토콜에 통합하여 반려동물의 스트레스를 최소화하면서 만성질환 관리를 강화할 수 있습니다. 이러한 추세는 반려동물 소유자를 직접 참여시켜 시장 접근성을 확대할 뿐만 아니라, 정기적인 검사와 결과의 원격 해석을 통해 지속적인 관계를 형성하는 구독형 서비스 모델도 뒷받침하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 반려동물 액체생검 시장 규모 : 제품별&CAGR(2026-2033)
세계의 반려동물 액체생검 시장 규모 : 순환 바이오마커별&CAGR(2026-2033)
세계의 반려동물 액체생검 시장 규모 : 기술별&CAGR(2026-2033)
세계의 반려동물 액체생검 시장 규모 : 용도별&CAGR(2026-2033)
세계의 반려동물 액체생검 시장 규모 : 최종 용도별&CAGR(2026-2033)
세계의 반려동물 액체생검 시장 규모&CAGR(2026-2033)
경쟁 정보
주요 기업 개요
결론과 제안
LSHGlobal Pet Liquid Biopsy Market size was valued at USD 245.6 Million in 2024 and is poised to grow from USD 283.67 Million in 2025 to USD 898.39 Million by 2033, growing at a CAGR of 15.5% during the forecast period (2026-2033).
Market insights into the Global Pet Liquid Biopsy sector reveal an increasing demand for noninvasive cancer diagnostics, driven by the rise in pet ownership and veterinary expenditures. This market features blood-based assays that detect tumor-derived cell-free DNA, allowing for early detection, staging, and treatment monitoring of companion animals. As pet owners seek advanced treatment options akin to family care, the need for innovative diagnostics intensifies. The evolution of this field from human oncology has led to companies developing canine and feline assays, with early adopters in specialty clinics showcasing their clinical value. Furthermore, AI technologies enhance diagnostic accuracy by improving detection of low-abundance tumor signals and linking molecular data with cytology, streamlining workflows and stimulating broader adoption for enhanced patient care.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pet Liquid Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pet Liquid Biopsy Market Segments Analysis
Global pet liquid biopsy market is segmented by product, circulating biomarkers, technology, application, end use and region. Based on product, the market is segmented into Consumables, Instruments and Software and Services. Based on circulating biomarkers, the market is segmented into Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA, Extracellular Vesicles and Other Biomarkers. Based on technology, the market is segmented into Multi-Gene Parallel Analysis and Single Gene Analysis. Based on application, the market is segmented into Treatment Monitoring, Prognosis and Recurrence Monitoring, Treatment Selection and Diagnosis and Screening. Based on end use, the market is segmented into Veterinary Hospitals, Pet Clinics and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pet Liquid Biopsy Market
The growing recognition of cancer risks in pets, coupled with a strong inclination among pet owners for less invasive diagnostic solutions, has significantly heightened interest in liquid biopsy testing. Veterinary professionals appreciate techniques that facilitate earlier detection and enhance treatment decision-making without the need for surgical interventions. Liquid biopsies fulfill these requirements by offering a means for routine monitoring and sample collection with minimal stress for the animals. This alignment of owner preferences with clinical endorsement paves the way for increased adoption of liquid biopsy services, expanding market potential and spurring investments in associated innovations and offerings.
Restraints in the Global Pet Liquid Biopsy Market
The Global Pet Liquid Biopsy market faces significant constraints due to inadequate insurance coverage and limited reimbursement options for advanced veterinary diagnostics. This situation leads to heightened out-of-pocket expenses for pet owners, deterring them from pursuing liquid biopsy tests and thereby affecting the revenue stability of veterinary clinics. The lack of established reimbursement frameworks can make veterinarians hesitant to recommend these diagnostic tests, as they may impose a financial strain on clients. Additionally, smaller veterinary practices may experience uncertainty about investing in the necessary technologies, hindering the routine use of liquid biopsies and obstructing the overall growth and sustainability of the market.
Market Trends of the Global Pet Liquid Biopsy Market
The Global Pet Liquid Biopsy market is witnessing a significant shift towards at-home testing, fueled by pet owners' desire for convenient and minimally invasive diagnostic options. Manufacturers are innovating simplified collection devices and straightforward instructions to facilitate compliance and promote early disease detection. Veterinary clinics and telemedicine providers are incorporating these home testing solutions into their care protocols, thereby enhancing chronic disease management while minimizing stress for pets. This trend not only expands market access by directly engaging pet owners but also supports subscription-based service models, fostering ongoing relationships through recurring testing and remote interpretation of results.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Pet Liquid Biopsy Market Size by Product & CAGR (2026-2033)
- Market Overview
- Consumables
- Kits and Reagents
- Assays and Panels
- Instruments
- Software and Services
Global Pet Liquid Biopsy Market Size by Circulating Biomarkers & CAGR (2026-2033)
- Market Overview
- Circulating Tumor Cells
- Circulating Tumor DNA
- Cell-Free DNA
- Extracellular Vesicles
- Other Biomarkers
Global Pet Liquid Biopsy Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Multi-Gene Parallel Analysis
- Single Gene Analysis
Global Pet Liquid Biopsy Market Size by Application & CAGR (2026-2033)
- Market Overview
- Treatment Monitoring
- Prognosis and Recurrence Monitoring
- Treatment Selection
- Diagnosis and Screening
Global Pet Liquid Biopsy Market Size by End Use & CAGR (2026-2033)
- Market Overview
- Veterinary Hospitals
- Pet Clinics
- Other End Users
Global Pet Liquid Biopsy Market Size & CAGR (2026-2033)
- North America (Product, Circulating Biomarkers, Technology, Application, End Use)
- US
- Canada
- Europe (Product, Circulating Biomarkers, Technology, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Circulating Biomarkers, Technology, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Circulating Biomarkers, Technology, Application, End Use)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Circulating Biomarkers, Technology, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Fidoforce
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vidium Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Heska Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PetDx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Volition
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Freenome Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vethos
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Embark Veterinary
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- One Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ellie Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TGen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MiDOG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Basepaws
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Antech Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pet-X
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AnimalBiome
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Exact Sciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
